Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Gross Margin (2017 - 2020)

Ironwood Pharmaceuticals (IRWD) has disclosed Gross Margin for 7 consecutive years, with 99.23% as the latest value for Q4 2020.

  • Quarterly Gross Margin rose 795.0% to 99.23% in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 99.19% through Dec 2020, up 644.0% year-over-year, with the annual reading at 99.19% for FY2020, 477.0% up from the prior year.
  • Gross Margin hit 99.23% in Q4 2020 for Ironwood Pharmaceuticals, down from 100.0% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q2 2020 to a low of 10631.5% in Q4 2018.
  • Historically, Gross Margin has averaged 575.32% across 4 years, with a median of 95.61% in 2018.
  • Biggest five-year swings in Gross Margin: plummeted -1072196bps in 2018 and later surged 1072278bps in 2019.
  • Year by year, Gross Margin stood at 90.46% in 2017, then crashed by -11852bps to 10631.5% in 2018, then skyrocketed by 101bps to 91.28% in 2019, then increased by 9bps to 99.23% in 2020.
  • Business Quant data shows Gross Margin for IRWD at 99.23% in Q4 2020, 100.0% in Q3 2020, and 100.0% in Q2 2020.